A male patient with chronic obstructive pulmonary disease (COPD) was prescribed theophylline. He noticed that his urine output had increased the following day. This action of the drug is mediated through which of the following receptors?

Correct Answer: B. Adenosine A1

Theophylline's diuretic effect is mediated through adenosine A1 receptor antagonism. Theophylline is a non-selective phosphodiesterase (PDE) inhibitor and a non-selective adenosine receptor antagonist. The diuretic action specifically results from blocking adenosine A1 receptors in the renal collecting duct. Adenosine normally acts on A1 receptors to inhibit cAMP production and suppress aquaporin-2 (AQP2) water channel insertion, thereby promoting water reabsorption. When theophylline blocks these A1 receptors, cAMP levels increase, leading to increased AQP2 translocation and paradoxically increased water channel activity—but the net effect in the kidney is reduced ADH sensitivity and increased urine output. Additionally, theophylline increases glomerular filtration rate through adenosine A1 antagonism in afferent arterioles, further promoting diuresis. This adenosine antagonism is distinct from theophylline's bronchodilatory effects, which are primarily mediated through PDE inhibition and increased intracellular cAMP in airway smooth muscle. In Indian clinical practice, theophylline-induced polyuria is a recognized side effect, particularly in COPD patients on chronic therapy, and contributes to electrolyte disturbances if not monitored.

Why the other options are wrong

A. Histone deacetylase — Histone deacetylase (HDAC) inhibition is not a mechanism of theophylline. While HDAC inhibitors are being researched for COPD due to their anti-inflammatory properties, theophylline does not act as an HDAC inhibitor. This is a distractor that confuses theophylline's actual mechanisms (PDE inhibition and adenosine antagonism) with unrelated epigenetic targets. Diuresis is not mediated by HDAC inhibition. C. Interleukin – 10 — Interleukin-10 (IL-10) is a cytokine, not a receptor that mediates drug action in the classical sense. Theophylline does not work through IL-10 signaling. This option conflates theophylline's immunomodulatory effects (which may involve cytokine modulation as a secondary consequence) with direct receptor-mediated mechanisms. IL-10 has no role in theophylline-induced diuresis. D. Beta 2 adrenergic receptors — While theophylline has mild beta-2 agonist-like effects through PDE inhibition (increasing cAMP), its diuretic action is not mediated through beta-2 adrenergic receptors. Beta-2 agonists promote bronchodilation and can cause tremor and tachycardia, but diuresis is not a primary beta-2 effect. The adenosine A1 antagonism is the specific mechanism for theophylline-induced polyuria, not adrenergic stimulation.

High-Yield Facts

Mnemonics

THEO-A1 (Theophylline Adenosine Antagonism) Theophylline blocks A1 → cAMP ↑ → AQP2 ↑ → Urine ↑. Remember: A1 antagonism = diuresis; PDE inhibition = bronchodilation. PDE vs A1 in Theophylline PDE inhibition = Pulmonary (bronchodilation). A1 antagonism = Aquaporin (diuresis). Two separate mechanisms, two separate effects.

NBE Trap

NBE pairs theophylline's bronchodilatory effect (PDE inhibition) with its diuretic effect, hoping students conflate the two mechanisms. The trap is assuming both effects share the same receptor target—they do not. Diuresis is purely adenosine A1 antagonism.

Clinical Pearl

In Indian COPD clinics, theophylline-induced polyuria is often mistaken for diabetes insipidus or uncontrolled diabetes. Checking serum potassium and magnesium is essential in patients on chronic theophylline, as adenosine A1 blockade-driven diuresis increases renal losses of these electrolytes, predisposing to arrhythmias—a critical safety issue in elderly COPD patients.

_Reference: KD Tripathi Pharmacology Ch. 27 (Respiratory Drugs); Harrison Principles of Internal Medicine Ch. 246 (COPD)_